DONATE

Free Support Line: 833-275-4222

Walk to End Bladder Cancer

Bladder Cancer Grants and Research Awards

Listed below are Bladder Cancer Advocacy Network (BCAN) research grants along with descriptions of each, deadlines, eligibility and more. For more information about these grants, please contact [email protected]. Please visit our Grants and Research page for more information about each award.

Research Innovation AwardCareer Development AwardYoung Investigator Award (YIA) & Young Investigator Award for Patient-Centered Clinical Research (YIA-PCC)John Quale Travel Fellowship
Application DeadlineLOI: January 2025
Invited Application: April 2025		October 2025February 2025March 2025
PurposeSupports exceptionally novel and creative projects with great potential to produce breakthroughs in our understanding of bladder cancer
Projects must be high-risk, high-reward vs. incremental in nature		Supports junior investigators who have received their initial faculty appointment to establish an independent bladder cancer research program and career pathSupports the development of research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer
YIA-PCC: Supports patient-oriented clinical bladder cancer research		The Travel Fellowship Program seeks to engage more early-career individuals with bladder cancer research interests including basic/translational scientists, urologists, medical and radiation oncologists, radiologists, pathologists, etc.
Research FocusMust have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma and include innovative approaches and new ideas (e.g., novel theoretical concepts, methodologies, instrumentation, interventions, etc.)
Basic, translational, clinical, or epidemiologic research is acceptable		Must have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma and must demonstrate the likelihood of translating new concepts into clinical practice
Translational, clinical, or epidemiological research is acceptable		Must be specific to bladder cancer and/or upper tract urothelial carcinoma 
YIA: Basic, translational, clinical, epidemiologic, bioengineering or any other field of research is acceptable
YIA-PCC: Must be patient-oriented clinical bladder cancer research (e.g., studies of shared decision making, access to care, quality of care, quality of life, health disparities, comparative effectiveness research, patient-centered outcomes research, and survivorship)		The travel fellowship seeks to engage early career investigators with interests related to bladder cancer, including basic scientists, urologists, oncologists, and pathologists
EligibilityFull-time, independent investigators
Investigators with relevant expertise outside of bladder cancer seeking to apply approaches to bladder cancer are encouraged
Applicant must be within the initial 7 years of their first full-time faculty appointment
Applicant may not hold the title of Associate or Full Professor
Applicant may not have previously secured major independent research funding (NIH R01 or equivalent)
Applicant must be within 6 years of completion of a professional degree or clinical training
Applicant may not hold the title of Associate Professor or higher		MDs and PhDs within the first 1-3 years of their first full-time faculty appointment at the time of application submission OR MD applicants in a research/scholar residency or fellowship program OR PhD applicants in a postdoctoral fellowship
Required DegreeApplicant must have a medical and/or doctoral degree. If the applicant’s primary area of expertise is outside of bladder cancer, including a Co-Primary Investigator with expertise in bladder cancer research is acceptable and recommendedMedical and/or doctoral degree in the biomedical sciences or a field applicable to health science research
YIA: Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research.
PCC: MD, DO, PhD, MD-PhD, MPH, MS, DNP, DScPAS or equivalent.		MD or PhD (see eligibility criteria)
Award Period2 years3 years1 yearBladder Cancer Think Tank Meeting 2025: July 30 – August 1, 2025
Total Funding
Indirect Costs		$300,000 ($150,000 per year)
A maximum of 10% of total direct costs may be used for indirect costs		$250,000 over 3 years
Up to 7% per year may be applied to indirect costs		$75,000
Not allowable		$2,000
N/A
Mentored Award?NoNoApplicant must have a mentor within or approved by the sponsoring institutionN/A

Related Stories